Ticker Details
Stoke Therapeutics, Inc.
IPO Date:	June 17, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.96B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.67 | 3.30%
Avg Daily Range (30 D):	$1.01 | 3.25%
Avg Daily Range (90 D):	$1.05 | 3.43%

Institutional Daily Volume
Avg Daily Volume:	.34M
Avg Daily Volume (30 D):	.53M
Avg Daily Volume (90 D):	.73M

Trade Size
Avg Trade Size (Sh.):	75
Avg Trade Size (Sh.) (30 D):	51
Avg Trade Size (Sh.) (90 D):	59

Institutional Trades
Total Institutional Trades:	1,432
Avg Institutional Trade:	$2.09M
Avg Institutional Trade (30 D):	$2.9M
Avg Institutional Trade (90 D):	$3.23M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.95M
Avg Closing Trade (30 D):	$3.76M
Avg Closing Trade (90 D):	$4.26M
Avg Closing Volume:	100.33K

News

Jun 28, 2024 @ 4:01 PM A Closer Look at 5 Analyst Recommendations For Sto... Source: Benzinga Insights

May 6, 2024 @ 3:01 PM Analyst Expectations For Stoke Therapeutics's Futu... Source: Benzinga Insights

May 6, 2024 @ 12:05 PM Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, T... Source: Zacks Equity Research

Apr 29, 2024 @ 2:00 PM Earnings Preview: Axsome Therapeutics (AXSM) Q1 Ea... Source: Zacks Equity Research

Apr 25, 2024 @ 2:01 PM Earnings Preview: Stoke Therapeutics, Inc. (STOK) ... Source: Zacks Equity Research

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$.73	$-.65	$-.4
Diluted EPS	$.68	$-.65	$-.4
Revenue	$205.63M	$10.63M	$13.82M
Gross Profit
Net Income / Loss	$40.57M	$-38.35M	$-23.48M
Operating Income / Loss	$27.2M	$-43.09M	$-27.3M
Cost of Revenue
Net Cash Flow	$-66.47M	$-18.15M	$-173.35M
PE Ratio	52.21

Splits
Jun 06, 2019	10:99